A Clinical Study of BT02 in Treating Patients With Advanced Lung Cancer
NCT07110363
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
58
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Malignant Solid Tumor
Advanced Lung Cancer
Non-Small Cell Lung Cancer
Small Cell Lung Cancer
Interventions
DRUG:
BT02
Sponsor
Biotroy Therapeutics